User profiles for J. Knox

Jennifer Knox

Medical Oncology, Princess Margaret Cancer Center, University of Toronto
Verified email at uhn.ca
Cited by 33433

[BOOK][B] The Works of John Knox

J Knox - 1864 - books.google.com
… In no instance do we find Knox himself using set forms of prayer; but that this Book was
sanctioned, if not partly prepared by him, is undeniable. The Presbyterian forms of worship were …

Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis

…, R Leibowitz-Amit, G Sonpavde, JJ Knox… - Journal of the …, 2014 - academic.oup.com
Background Inflammation may play an important role in cancer progression, and a high
neutrophil-to-lymphocyte ratio (NLR) has been reported to be a poor prognostic indicator in …

Pectin: new insights into an old polymer are starting to gel

WGT Willats, JP Knox, JD Mikkelsen - Trends in food science & technology, 2006 - Elsevier
Pectin is a high value functional food ingredient widely used as a gelling agent and stabilizer.
It is also an abundant, ubiquitous and multifunctional component of the cell walls of all …

Pectin: cell biology and prospects for functional analysis

WGT Willats, L McCartney, W Mackie, JP Knox - Plant molecular biology, 2001 - Springer
Pectin is a major component of primary cell walls of all land plants and encompasses a
range of galacturonic acid-rich polysaccharides. Three major pectic polysaccharides (…

Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial

…, A Vogel, D Sarker, G Verset, SL Chan, J Knox… - The Lancet …, 2018 - thelancet.com
Background Immune checkpoint blockade therapy has shown promising results in patients
with advanced hepatocellular carcinoma. We aimed to assess the efficacy and safety of …

[PDF][PDF] Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor–targeted agents: results …

…, T Cheng, S North, P Venner, JJ Knox… - Journal of clinical …, 2009 - imdconline.com
… N Engl J Med 356:115-124, 2007 … J Clin Oncol 20:2376-2381, 2002 26. Cheville JC,
Lohse CM, Zincke H, et al: Comparisons of outcome and prognostic features among …

Efficacy and safety of nivolumab plus ipilimumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib: the CheckMate 040 …

…, M Kudo, MM Hou, A Matilla, F Tovoli, JJ Knox… - JAMA …, 2020 - jamanetwork.com
Importance Most patients with hepatocellular carcinoma (HCC) are diagnosed with advanced
disease not eligible for potentially curative therapies; therefore, new treatment options are …

Large increases in flood magnitude in response to modest changes in climate

JC Knox - Nature, 1993 - nature.com
RECENT examinations of the possible hydrological response to global warming have
emphasized changes in average conditions, rather than individual flooding events 1–5 . Historical …

Pembrolizumab as second-line therapy in patients with advanced hepatocellular carcinoma in KEYNOTE-240: a randomized, double-blind, phase III trial

…, T Yau, M Garrido, SL Chan, J Knox… - Journal of Clinical …, 2020 - ascopubs.org
PURPOSE Pembrolizumab demonstrated antitumor activity and safety in the phase II
KEYNOTE-224 trial in previously treated patients with advanced hepatocellular carcinoma (HCC). …

[PDF][PDF] Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses

…, OY Soliman, M Pine, P Hicks, TB Manzoni, JJ Knox… - Immunity, 2021 - cell.com
Adjuvants are critical for improving the quality and magnitude of adaptive immune responses
to vaccination. Lipid nanoparticle (LNP)-encapsulated nucleoside-modified mRNA …